The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

ASAH1  -  N-acylsphingosine amidohydrolase (acid...

Homo sapiens

Synonyms: AC, ACDase, ASAH, Acid CDase, Acid ceramidase, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of ASAH1

  • Interestingly, 10 of 15 primary prostate cancers examined by Western blotting overexpressed acid ceramidase (AC), suggesting that ceramide deacylation might serve to negate elevated levels of ceramide, creating a more antiapoptotic phenotype [1].
  • Although the molecular basis of pseudohypoparathyroidism type 1b (PHP type 1b) remains unknown, a defect in imprinting at the GNAS1 locus has been suggested by the consistent finding of paternal-specific patterns of DNA methylation on maternally inherited GNAS1 alleles [2].
  • Eight of the 14 patients had relapsed or had refractory non-Hodgkin's lymphoma (NHL) and received rhGM-CSF after intensive chemotherapy with novantrone (NO) and high-dose Ara-C (AC) (NOAC) as salvage regimen [3].
  • Hypoxia increased AC RNA expression; the AC inhibitor NOE enhanced 4-HPR-induced ceramide species increase and cytotoxicity [4].
  • The PHP domain is highly conserved in all bacterial polymerase III alpha subunits, but in proteobacteria and mycoplasmas, the conserved motifs are distorted, suggesting a loss of the enzymatic activity [5].
 

Psychiatry related information on ASAH1

  • Significantly higher olfaction thresholds were observed in UV line and AC line workers and finishers of UV/AC surface-coated wood products [6].
  • I believe these data are essential to those in decision making positions and ASAHP would be an appropriate organization to collect and disseminate these data [7].
  • Aberrant AC activity also has been described in Alzheimer's disease, and overexpression of AC may prevent insulin resistant (Type II) diabetes induced by free fatty acids [8].
 

High impact information on ASAH1

  • In patients presumed to have the most severe GnRH deficiency (PHP), responses of both FSH and luteinizing hormone (LH) were small and delayed, and no increase in plasma estradiol occurred during the 5 d of GnRH injections [9].
  • Here, we show that the abundant DEAD-box RNA helicase p72, but not its close relative p68, affects the splicing of alternative exons containing AC-rich exon enhancer elements [10].
  • Interestingly, knockdown of endogenous AC by RNA interference attenuated cyclooxygenase 2 induction by TNFalpha and subsequent PGE(2) biosynthesis [11].
  • Frequency of Tax-specific CD8(+) T cells in AC was related to proviral load in HLA-A*0201 [12].
  • In addition, the AC tyrosines regulate tyrosine phosphorylation of Vav1 [13].
 

Chemical compound and disease context of ASAH1

 

Biological context of ASAH1

  • Acid ceramidase (N-acylsphingosine deacylase, EC 3.5.1.23) is the lysosomal enzyme catalyzing the hydrolysis of ceramide to sphingosine and free fatty acid [19].
  • A homoallelic point mutation (T222K) was also identified in the AC gene of a patient suffering from Farber disease, further confirming the authenticity of the full-length cDNA [20].
  • This was confirmed in AC-overexpressing cells in which we observed decreased sensitivity to apoptosis following treatment with Apoptin [1].
  • Finally, three new missense mutations, E138V, R254G, and P362R, were identified in the human AC gene from FD patients [21].
  • These results further underscore the genetic heterogeneity of AHO and provides further evidence that PHP Ia and PPHP are two clinical presentations of a common genetic defect [22].
 

Anatomical context of ASAH1

  • Secretion of hAC by either fibroblasts or acid ceramidase cDNA-transfected COS cells is extraordinarily low [23].
  • Transient expression of the full-length cDNA in COS-1 cells led to a 10-fold increase in AC activity [20].
  • The biosynthesis of human acid ceramidase (hAC) starts with the expression of a single precursor polypeptide of approximately 53-55 kDa, which is subsequently processed to the mature, heterodimeric enzyme (40 + 13 kDa) in the endosomes/lysosomes [23].
  • Two minor AC transcripts of 1.7 and 1.2 kb also were detected in heart and skeletal muscle [21].
  • Metabolic labeling studies in fibroblasts of four patients showed that even though acid ceramidase precursor protein was synthesized in these individuals, rapid proteolysis of the mutated, mature acid ceramidase occurred within the lysosome [24].
 

Associations of ASAH1 with chemical compounds

  • Human acid ceramidase ((AC) N-acylsphingosine amidohydrolase, EC 3.5. 1.23) hydrolyzes the sphingolipid ceramide into sphingosine and free fatty acid [20].
  • 2-Anthracenecarboxylic acid (AC) makes a very stable 1:2 inclusion complex with gamma-cyclodextrin (gamma-CDx) (K(1) = 161 +/- 25 M(-1), K(2) = 38 500 +/- 3300 M(-1) at 25 degrees C) [25].
  • In these cases, the pyrophosphate may be hydrolyzed by a stand-alone phosphatase, and candidates for such a role were identified among bacterial PHP superfamily members [5].
  • The predicted catalytic site of the PHP superfamily consists of four motifs containing conserved histidine residues that are likely to be involved in metal-dependent catalysis of phosphoester bond hydrolysis [5].
  • The alpha subunits of bacterial DNA polymerase III and two distinct family X DNA polymerases are shown to contain an N-terminal domain that defines a novel enzymatic superfamily, designated PHP, after polymerase and histidinol phosphatase [5].
 

Analytical, diagnostic and therapeutic context of ASAH1

  • The human AC gene was mapped to the chromosomal region 8p21.3-p22 by in situ hybridization and FISH analyses, syntenic with the mouse chromosomal location [21].
  • One PHP 1b kindred (family M) was informative for a intragenic polymorphism in exon 3 of the PTH gene detected by PCR amplification and resolved by denaturing gradient gel electrophoresis [26].
  • The main outcome measures were CAC and AC, measured by electron beam tomography [27].
  • Interestingly, total testosterone was an independent risk factor for AC in all subjects after controlling for PCOS, age, and body mass index (P = 0.034) [27].
  • The expression of AC in normal thyroids and thyroid tumors was examined by semi-quantitative reverse-transcription-polymerase-chain-reaction (RT-PCR) [28].

References

  1. Modulation of Ceramide Metabolism Enhances Viral Protein Apoptin's Cytotoxicity in Prostate Cancer. Liu, X., Elojeimy, S., El-Zawahry, A.M., Holman, D.H., Bielawska, A., Bielawski, J., Rubinchik, S., Guo, G.W., Dong, J.Y., Keane, T., Hannun, Y.A., Tavassoli, M., Norris, J.S. Mol. Ther. (2006) [Pubmed]
  2. Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1. Jan de Beur, S., Ding, C., Germain-Lee, E., Cho, J., Maret, A., Levine, M.A. Am. J. Hum. Genet. (2003) [Pubmed]
  3. Activation of lymphocytes induced by recombinant human granulocyte-macrophage colony-stimulating factor in patients with malignant lymphoma. Ho, A.D., Haas, R., Wulf, G., Knauf, W., Ehrhardt, R., Heilig, B., Körbling, M., Schulz, G., Hunstein, W. Blood (1990) [Pubmed]
  4. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators. Batra, S., Reynolds, C.P., Maurer, B.J. Cancer Res. (2004) [Pubmed]
  5. Phosphoesterase domains associated with DNA polymerases of diverse origins. Aravind, L., Koonin, E.V. Nucleic Acids Res. (1998) [Pubmed]
  6. Upper airway symptoms and function in wood surface coating industry workers. Holmström, M., Granstrand, P., Nylander-French, L.A., Rosén, G. Am. J. Ind. Med. (1995) [Pubmed]
  7. The 1996 National Pilot Data Collection Project of the Association of Schools of Allied Health Professions. Wingate, L. Journal of allied health. (1997) [Pubmed]
  8. Acid ceramidase and human disease. Park, J.H., Schuchman, E.H. Biochim. Biophys. Acta (2006) [Pubmed]
  9. Selective inhibition of follicle-stimulating hormone secretion by estradiol. Mechanism for modulation of gonadotropin responses to low dose pulses of gonadotropin-releasing hormone. Marshall, J.C., Case, G.D., Valk, T.W., Corley, K.P., Sauder, S.E., Kelch, R.P. J. Clin. Invest. (1983) [Pubmed]
  10. Regulation of alternative splicing by the ATP-dependent DEAD-box RNA helicase p72. Hönig, A., Auboeuf, D., Parker, M.M., O'Malley, B.W., Berget, S.M. Mol. Cell. Biol. (2002) [Pubmed]
  11. Acid ceramidase but not acid sphingomyelinase is required for tumor necrosis factor-{alpha}-induced PGE2 production. Zeidan, Y.H., Pettus, B.J., Elojeimy, S., Taha, T., Obeid, L.M., Kawamori, T., Norris, J.S., Hannun, Y.A. J. Biol. Chem. (2006) [Pubmed]
  12. Reduced Frequency, Diversity, and Function of Human T Cell Leukemia Virus Type 1-Specific CD8+ T Cell in Adult T Cell Leukemia Patients. Kozako, T., Arima, N., Toji, S., Masamoto, I., Akimoto, M., Hamada, H., Che, X.F., Fujiwara, H., Matsushita, K., Tokunaga, M., Haraguchi, K., Uozumi, K., Suzuki, S., Takezaki, T., Sonoda, S. J. Immunol. (2006) [Pubmed]
  13. Vav1 Acidic Region Tyrosine 174 Is Required for the Formation of T Cell Receptor-induced Microclusters and Is Essential in T Cell Development and Activation. Miletic, A.V., Sakata-Sogawa, K., Hiroshima, M., Hamann, M.J., Gomez, T.S., Ota, N., Kloeppel, T., Kanagawa, O., Tokunaga, M., Billadeau, D.D., Swat, W. J. Biol. Chem. (2006) [Pubmed]
  14. Selective resistance to parathyroid hormone in cultured skin fibroblasts from patients with pseudohypoparathyroidism type Ib. Silve, C., Santora, A., Breslau, N., Moses, A., Spiegel, A. J. Clin. Endocrinol. Metab. (1986) [Pubmed]
  15. Association of a variant of the angiotensinogen gene with pure type of hypertension in pregnancy in the Japanese: implication of a racial difference and significance of an age factor. Kobashi, G., Hata, A., Shido, K., Kato, E.H., Yamada, H., Fujimoto, S., Kishi, R., Kondo, K. Am. J. Med. Genet. (1999) [Pubmed]
  16. Mitoxantrone/high-dose Ara-C and recombinant human GM-CSF in the treatment of refractory non-Hodgkin's lymphoma. A pilot study. Ho, A.D., Del Valle, F., Engelhard, M., Hiddemann, W., Rückle, H., Schlimok, G., Haas, R., Thiel, E., Andreesen, R., Fiedler, W. Cancer (1990) [Pubmed]
  17. Limited availability of nutritional vitamin D causing inappropriate treatment of vitamin D deficiency rickets with a response resembling pseudohypoparathyroidism type II in a Japanese patient. Inamo, Y. J. Endocrinol. Invest. (2005) [Pubmed]
  18. Effect of chronic renal hemodialysis on serum total, free and acyl carnitine concentrations in adult chronic pyelonephritis patients. Alhomida, A.S. Arch. Med. Res. (1997) [Pubmed]
  19. Purification, characterization, and biosynthesis of human acid ceramidase. Bernardo, K., Hurwitz, R., Zenk, T., Desnick, R.J., Ferlinz, K., Schuchman, E.H., Sandhoff, K. J. Biol. Chem. (1995) [Pubmed]
  20. Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification Of the first molecular lesion causing Farber disease. Koch, J., Gärtner, S., Li, C.M., Quintern, L.E., Bernardo, K., Levran, O., Schnabel, D., Desnick, R.J., Schuchman, E.H., Sandhoff, K. J. Biol. Chem. (1996) [Pubmed]
  21. The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression. Li, C.M., Park, J.H., He, X., Levy, B., Chen, F., Arai, K., Adler, D.A., Disteche, C.M., Koch, J., Sandhoff, K., Schuchman, E.H. Genomics (1999) [Pubmed]
  22. Identification of two novel deletion mutations within the Gs alpha gene (GNAS1) in Albright hereditary osteodystrophy. Yu, D., Yu, S., Schuster, V., Kruse, K., Clericuzio, C.L., Weinstein, L.S. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
  23. Human acid ceramidase: processing, glycosylation, and lysosomal targeting. Ferlinz, K., Kopal, G., Bernardo, K., Linke, T., Bar, J., Breiden, B., Neumann, U., Lang, F., Schuchman, E.H., Sandhoff, K. J. Biol. Chem. (2001) [Pubmed]
  24. Molecular analysis of acid ceramidase deficiency in patients with Farber disease. Bär, J., Linke, T., Ferlinz, K., Neumann, U., Schuchman, E.H., Sandhoff, K. Hum. Mutat. (2001) [Pubmed]
  25. Supramolecular catalysis of the enantiodifferentiating [4 + 4] photocyclodimerization of 2-anthracenecarboxylate by gamma-cyclodextrin. Nakamura, A., Inoue, Y. J. Am. Chem. Soc. (2003) [Pubmed]
  26. Pseudohypoparathyroidism 1b: exclusion of parathyroid hormone and its receptors as candidate disease genes. Jan de Beur, S.M., Ding, C.L., LaBuda, M.C., Usdin, T.B., Levine, M.A. J. Clin. Endocrinol. Metab. (2000) [Pubmed]
  27. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. Talbott, E.O., Zborowski, J.V., Rager, J.R., Boudreaux, M.Y., Edmundowicz, D.A., Guzick, D.S. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  28. Rapid screening of specific changes in mRNA in thyroid carcinomas by sequence specific-differential display: decreased expression of acid ceramidase mRNA in malignant and benign thyroid tumors. Maeda, I., Takano, T., Matsuzuka, F., Maruyama, T., Higashiyama, T., Liu, G., Kuma, K., Amino, N. Int. J. Cancer (1999) [Pubmed]
 
WikiGenes - Universities